Discovery & Innovation
This is Part 3 in a three-part series on patient-centered outcomes. (Check out Part 1 and Part 2). Patient perspective (patient-centered outcomes...
Modern medicine has made incredible advances with treatments that have changed the prospects for many diseases. The healthcare and pharmaceutical...
This is Part 2 in a three-part series on patient-centered outcomes. (Check out Part 1 and Part 3). A personalized medicine approach to clinical...
This is Part 1 in a three-part series on patient-centered outcomes. (Check out Part 2 and Part 3). In different regulatory and research settings...
Targeted based drug discovery has been a mainstay of pharmaceutical pipelines for the last 20 years. Identifying and validating novel drug...
Steve Blank wrote an excellent 3 part blog series last week. We covered Part 1 which described the challenges Life Science companies face in...
Interesting news for those thinking about personalized medicine and drug development: children born to mothers after bariatric gastrointestinal...
Life science companies are known to be one of the most expensive and difficult to start up. We look for an answer as to why in an excellent article...
Almost weekly in the news there is an article about a new scientific breakthrough and how animal models were instrumental in making this discovery...
An oncogene is a gene that can potentially cause cancer. RAS is a common class of oncogene and the focus of researchers worldwide, particularly at...